Letter to the editor: Neutralizing antibodies for the treatment of COVID-19.
10.1016/j.apsb.2020.10.025
- Author:
Zeqi ZHOU
1
;
Xiangbin WANG
2
;
Yankai FU
1
;
Xiqing ZHANG
1
;
Changxiao LIU
3
Author Information
1. Dynamiker Biotechnology Sub-Center, Beijing Key Laboratory for Mechanism Study and Precision Diagnosis of Invasive Fungal Diseases, Tianjin 300467, China.
2. Beijing Antai Zhiyuan Technology Co., Ltd., Beijing 102206, China.
3. State Key Laboratory of Drug Delivery Technology and Pharmacokinetics, Tianjin Institute of Pharmaceutical Research, Tianjin 300462, China.
- Publication Type:Journal Article
- Keywords:
COVID-19;
Neutralizing antibody therapy;
SARS-CoV-2
- From:
Acta Pharmaceutica Sinica B
2021;11(1):304-307
- CountryChina
- Language:English
